- Home
- SPT vs BBNX Comparison
SPT vs BBNX Comparison
Compare SPT & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPT | BBNX |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | N/A | 423 |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 449.6M | 493.1M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | SPT | BBNX |
|---|---|---|
| Price | $8.15 | $12.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | $11.75 | ★ $23.80 |
| AVG Volume (30 Days) | ★ 1.5M | 621.7K |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.11 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $457,547,000.00 | N/A |
| Revenue This Year | $8.86 | $34.90 |
| Revenue Next Year | $8.04 | $34.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.72 | N/A |
| 52 Week Low | $4.92 | $8.80 |
| 52 Week High | $22.59 | $32.71 |
Technical Indicators
Market Signals| Indicator | SPT | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 71.63 | 70.11 |
| Support Level | $5.94 | $12.71 |
| Resistance Level | $11.50 | $13.35 |
| Average True Range (ATR) | 0.36 | 0.71 |
| MACD | 0.12 | 0.35 |
| Stochastic Oscillator | 97.89 | 97.42 |
Price Performance
Historical ComparisonAbout SPT Sprout Social Inc
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.